BOUNDLESS THERAPEUTIC INGENUITY Trademark
Trademark Overview
On Wednesday, February 17, 2021, a trademark application was filed for BOUNDLESS THERAPEUTIC INGENUITY with the United States Patent and Trademark Office. The USPTO has given the BOUNDLESS THERAPEUTIC INGENUITY trademark a serial number of 90533150. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, September 26, 2022. This trademark is owned by Tarsus Pharmaceuticals, Inc.. The BOUNDLESS THERAPEUTIC INGENUITY trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing medical and pharmaceutical information on the topic of health issues, health awareness, medical information, and pharmaceutical preparations for human use
Pharmaceutical research and development; providing medical and scientific research information in the fields of pharmaceuticals, therapies, diseases, and disorders
General Information
| Serial Number | 90533150 |
| Word Mark | BOUNDLESS THERAPEUTIC INGENUITY |
| Filing Date | Wednesday, February 17, 2021 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, September 26, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Pseudo Mark | BOUND LESS THERAPEUTIC INGENUITY |
| Goods and Services | Providing medical and pharmaceutical information on the topic of health issues, health awareness, medical information, and pharmaceutical preparations for human use |
| Goods and Services | Pharmaceutical research and development; providing medical and scientific research information in the fields of pharmaceuticals, therapies, diseases, and disorders |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 19, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 19, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Tarsus Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 |
Trademark Events
| Event Date | Event Description |
| Monday, September 26, 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Monday, September 26, 2022 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Monday, September 26, 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, March 9, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, March 9, 2022 | FINAL REFUSAL E-MAILED |
| Wednesday, March 9, 2022 | FINAL REFUSAL WRITTEN |
| Thursday, January 13, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 12, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 12, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 14, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, July 14, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, July 14, 2021 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 29, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, May 19, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, February 20, 2021 | NEW APPLICATION ENTERED IN TRAM |
